These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33588594)

  • 21. Burden of oral anticoagulation in embolic stroke of undetermined source without atrial fibrillation.
    Witte KK; Tsivgoulis G; Reynolds MR; Tsintzos SI; Eggington S; Ismyrloglou E; Lyon J; Huynh M; Egea M; de Brouwer B; Ziegler PD; Franco N; Joglekar R; Rosemas SC; Liu S; Thijs V
    BMC Cardiovasc Disord; 2021 Mar; 21(1):160. PubMed ID: 33789592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial.
    Dans AL; Connolly SJ; Wallentin L; Yang S; Nakamya J; Brueckmann M; Ezekowitz M; Oldgren J; Eikelboom JW; Reilly PA; Yusuf S
    Circulation; 2013 Feb; 127(5):634-40. PubMed ID: 23271794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ticagrelor Versus Aspirin in Acute Embolic Stroke of Undetermined Source.
    Amarenco P; Albers GW; Denison H; Easton JD; Evans SR; Held P; Hill MD; Jonasson J; Kasner SE; Ladenvall P; Minematsu K; Molina CA; Wang Y; Wong KSL; Johnston SC;
    Stroke; 2017 Sep; 48(9):2480-2487. PubMed ID: 28720658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rivaroxaban versus aspirin for secondary prevention of ischaemic stroke in patients with cancer: a subgroup analysis of the NAVIGATE ESUS randomized trial.
    Martinez-Majander N; Ntaios G; Liu YY; Ylikotila P; Joensuu H; Saarinen J; Perera KS; Marti-Fabregas J; Chamorro A; Rudilosso S; Prats-Sanchez L; Berkowitz SD; Mundl H; Themeles E; Tiainen M; Demchuk A; Kasner SE; Hart RG; Tatlisumak T;
    Eur J Neurol; 2020 May; 27(5):841-848. PubMed ID: 32056346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Embolic Stroke of Undetermined Source: JACC Review Topic of the Week.
    Ntaios G
    J Am Coll Cardiol; 2020 Jan; 75(3):333-340. PubMed ID: 31976872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracranial and systemic atherosclerosis in the NAVIGATE ESUS trial: Recurrent stroke risk and response to antithrombotic therapy.
    Ameriso SF; Amarenco P; Pearce LA; Perera KS; Ntaios G; Lang W; Bereczki D; Uchiyama S; Kasner SE; Yoon BW; Lavados P; Firstenfeld A; Mikulik R; Povedano GP; Ferrari J; Mundl H; Berkowitz SD; Connolly SJ; Hart RG
    J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104936. PubMed ID: 32689594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rivaroxaban versus aspirin for prevention of covert brain infarcts in patients with embolic stroke of undetermined source: NAVIGATE ESUS MRI substudy.
    Sharma M; Smith EE; Pearce LA; Perera KS; Kasner SE; Yoon BW; Ameriso SF; Puig J; Damgaard D; Fiebach JB; Muir KW; Veltkamp RC; Toni DS; Shamalov N; Gagliardi RJ; Mikulik R; Engelter ST; Bereczki D; O'Donnell MJ; Saad F; Shoamanesh A; Berkowitz SD; Mundl H; Hart RG;
    Int J Stroke; 2022 Aug; 17(7):799-805. PubMed ID: 34791941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aortic Arch Atherosclerosis in Patients With Embolic Stroke of Undetermined Source: An Exploratory Analysis of the NAVIGATE ESUS Trial.
    Ntaios G; Pearce LA; Meseguer E; Endres M; Amarenco P; Ozturk S; Lang W; Bornstein NM; Molina CA; Pagola J; Mundl H; Berkowitz SD; Liu YY; Sen S; Connolly SJ; Hart RG
    Stroke; 2019 Nov; 50(11):3184-3190. PubMed ID: 31526123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of Recurrent Ischemic Stroke in Patients with Embolic Strokes of Undetermined Source and Effects of Rivaroxaban Versus Aspirin According to Risk Status: The NAVIGATE ESUS Trial.
    Hart RG; Veltkamp RC; Sheridan P; Sharma M; Kasner SE; Bangdiwala SI; Ntaios G; Shoamanesh A; Ameriso SF; Toni D; Czlonkowska A; Lindgren A; Hankey GJ; Perera KS; Shuaib A; Coutts SB; Gagliardi RJ; Berkowitz SD; Mundl H; Peters G; Connolly SJ;
    J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2273-2279. PubMed ID: 31160218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ticagrelor in Acute Stroke or Transient Ischemic Attack in Asian Patients: From the SOCRATES Trial (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes).
    Wang Y; Minematsu K; Wong KS; Amarenco P; Albers GW; Denison H; Easton JD; Evans SR; Held P; Jonasson J; Molina CA; Johnston SC;
    Stroke; 2017 Jan; 48(1):167-173. PubMed ID: 27899747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and Safety of Ticagrelor in Relation to Aspirin Use Within the Week Before Randomization in the SOCRATES Trial.
    Wong KSL; Amarenco P; Albers GW; Denison H; Easton JD; Evans SR; Held P; Himmelmann A; Kasner SE; Knutsson M; Ladenvall P; Minematsu K; Molina CA; Wang Y; Johnston SC;
    Stroke; 2018 Jul; 49(7):1678-1685. PubMed ID: 29915123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rivaroxaban versus aspirin on functional and cognitive outcomes after embolic stroke of undetermined source: NAVIGATE ESUS trial.
    Bosch J; Pearce LA; Sharma M; Canavan M; Whiteley WN; Mikulík R; Mundl H; Yusuf S; Hart RG; O'Donnell MJ
    J Stroke Cerebrovasc Dis; 2022 May; 31(5):106404. PubMed ID: 35292423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy).
    Reilly PA; Lehr T; Haertter S; Connolly SJ; Yusuf S; Eikelboom JW; Ezekowitz MD; Nehmiz G; Wang S; Wallentin L;
    J Am Coll Cardiol; 2014 Feb; 63(4):321-8. PubMed ID: 24076487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Lesion Complexity and Clinical Risk Factors on the Efficacy and Safety of Dabigatran Dual Therapy Versus Warfarin Triple Therapy in Atrial Fibrillation After Percutaneous Coronary Intervention: A Subgroup Analysis From the REDUAL PCI Trial.
    Berry NC; Mauri L; Steg PG; Bhatt DL; Hohnloser SH; Nordaby M; Miede C; Kimura T; Lip GYH; Oldgren J; Ten Berg JM; Cannon CP
    Circ Cardiovasc Interv; 2020 Apr; 13(4):e008349. PubMed ID: 32252548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: Design of the NAVIGATE ESUS randomized trial.
    Hart RG; Sharma M; Mundl H; Shoamanesh A; Kasner SE; Berkowitz SD; Pare G; Kirsch B; Pogue J; Pater C; Peters G; Davalos A; Lang W; Wang Y; Wang Y; Cunha L; Eckstein J; Tatlisumak T; Shamalov N; Mikulik R; Lavados P; Hankey GJ; Czlonkowska A; Toni D; Ameriso SF; Gagliardi RJ; Amarenco P; Bereczki D; Uchiyama S; Lindgren A; Endres M; Brouns R; Yoon BW; Ntaios G; Veltkamp R; Muir KW; Ozturk S; Arauz A; Bornstein N; Bryer A; O'Donnell MJ; Weitz J; Peacock F; Themeles E; Connolly SJ
    Eur Stroke J; 2016 Sep; 1(3):146-154. PubMed ID: 31008276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Embolic strokes of undetermined source: theoretical construct or useful clinical tool?
    Tsivgoulis G; Katsanos AH; Köhrmann M; Caso V; Lemmens R; Tsioufis K; Paraskevas GP; Bornstein NM; Schellinger PD; Alexandrov AV; Krogias C
    Ther Adv Neurol Disord; 2019; 12():1756286419851381. PubMed ID: 31205494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time to Loading Dose and Risk of Recurrent Events in the SOCRATES Trial.
    Molina CA; Johnston SC; Ladenvall P; Amarenco P; Albers GW; Denison H; Easton JD; Evans SR; Held P; Knutsson M; Minematsu K; Röther J; Wang Y; Wong KSL;
    Stroke; 2019 Mar; 50(3):675-682. PubMed ID: 30776996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reexamination of the Embolic Stroke of Undetermined Source Concept.
    Albers GW; Bernstein R; Brachmann J; Camm AJ; Fromm P; Goto S; Granger CB; Hohnloser SH; Hylek E; Krieger D; Passman R; Pines JM; Kowey P
    Stroke; 2021 Aug; 52(8):2715-2722. PubMed ID: 34192898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Homocysteine Level Predicts Response to Dual Antiplatelet in Women With Minor Stroke or Transient Ischemic Attack: Subanalysis of the CHANCE Trial.
    Li J; Wang Y; Li H; Zuo Z; Lin J; Wang A; Zhao X; Liu L; Wang Y;
    Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):839-846. PubMed ID: 31941381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dabigatran versus warfarin: effects on ischemic and hemorrhagic strokes and bleeding in Asians and non-Asians with atrial fibrillation.
    Hori M; Connolly SJ; Zhu J; Liu LS; Lau CP; Pais P; Xavier D; Kim SS; Omar R; Dans AL; Tan RS; Chen JH; Tanomsup S; Watanabe M; Koyanagi M; Ezekowitz MD; Reilly PA; Wallentin L; Yusuf S;
    Stroke; 2013 Jul; 44(7):1891-6. PubMed ID: 23743976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.